NICOLE GOLAK: Open Payments
NPI 1386186971 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 6 payments from 5 companies in 2025. Trend: 2023 $399 · 2024 $290 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Eisai Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: LYNPARZA, OPDIVO, Lenvima, INJECTAFER, ERLEADA.
Industry payments across IL — which companies pay providers there.
